Will Supply Chains Wobble if ‘90 Deals in 90 Days’ Fails?

The Trump administration's "90 deals in 90 days" trade initiative has largely failed, with minimal progress and extended deadlines, significantly heightening global supply chain uncertainty. This ongoing tariff pressure, which 90% of US businesses cite as a concern, is prompting companies to diversify sourcing, evidenced by declining Chinese exports to the US while increasing to other regions. With US effective tariffs now estimated at 15% and a weakening dollar exacerbating costs, businesses face rising expenses and increased economic slowdown risks, forcing a strategic reconfiguration of global production footprints and procurement strategies to mitigate exposure.

Analysis

The failure of the Trump administration's "90 deals in 90 days" trade initiative to produce significant agreements by its July 9 deadline has amplified global supply chain uncertainty. This is not a minor issue, as a Gallagher survey indicates 90% of US business owners are concerned about the impact of tariffs on their operations. The administration's policy of using trade deficits as a justification for tariffs against key partners like Japan and South Korea is creating diplomatic friction rather than fostering negotiation. This has led to tangible shifts in trade dynamics: Chinese exports to the US have fallen 9.7% this year, while its exports to Africa and ASEAN have surged 18.9% and 12.2% respectively, indicating a deliberate reconfiguration of global supply chains to bypass the US. The economic pressure is intensified by an estimated 15% effective US tariff rate and a 10% decline in the US dollar, which contradicts the Treasury's hope that a strong currency would mitigate inflation. Corporate executives are openly signaling distress; Intel's CFO cited a growing probability of recession, and Skechers' COO described the environment as too volatile for reliable planning. Furthermore, the administration's threat of 200% tariffs on pharmaceuticals and potential levies on semiconductors introduces significant sector-specific risk, forcing companies to plan for severe cost increases and disruptions.

Key Decisions for Investors

• Investors should review portfolio exposure to companies highly dependent on US-centric global supply chains, particularly those with deep ties to Japan, South Korea, and Mexico, which are directly targeted by the administration's trade policy.
• The explicit threat of 200% tariffs on pharmaceuticals and potential tariffs on semiconductors warrants a cautious stance on these sectors; monitor policy announcements closely for catalysts that could trigger significant repricing.
• Consider looking for companies and logistics providers that are benefiting from the re-routing of global trade away from the US, such as those with growing exposure to ASEAN and other non-US trade blocs.
• Pay close attention to upcoming corporate earnings calls for management commentary on margin pressure, inventory levels, and any revisions to guidance specifically citing tariffs and the weaker dollar as headwinds.